Skip to main content
4.10
0.10 (2.50%)
GBX
09:32 GMT 21/11/2024
Home
About Us
Board of Directors
Senior Management
Scientific Advisory Board
Our Facilities
Portfolio
MDK Antibody
MDK Oligo
MDK mRNA
STAT-6 siRNA
MK Cell
What is Midkine
Partnering
Cancer Research Centres
Licencing
Investors
Share price
Results Centre
Analyst Research
Corporate Governance
Shareholder Information
Shareholder Documents
Advisors
Media Centre
Regulatory News
Presentations
Videos
Email news alert
Contact
Home
About Us
Portfolio
Partnering
Investors
Media Centre
Contact
Investors
Share price
Results Centre
Analyst Research
Corporate Governance
Shareholder Information
Shareholder Documents
Advisors
Results Centre
All
2024
2023
2022
2021
30 June 2024
Interim Results to 30 June 2024
Read the Report